Reading it Berg’s wording doesn’t exactly make it clear but I would assume that they are engaging with all commercial contract providers including the one they lost, but he could be just referring to existing ones where Amarin had exclusivity.
I’m sure they’d try to win it back if there was an opportunity.
“Looking at 2025, we submitted what we believe to be competitive offers for 2025, and plans are now in the process of making their decisions regarding formulary coverage to start 2025.
The feedback we've received to-date regarding our offers has been positive, but it's far too early to make any predictions regarding 2025 coverage status even at the plans that have given us positive feedback.”